BioElectronics Corp. Announces Study Results Show That ActiPatch is More Effective than Acetaminophen in the Reduction of Muscle Soreness
Ft Lauderdale, Florida 11/18/2009 09:45 PM GMT (TransWorldNews)
BioElectronics Corp. (BIEL.PKS) announce effectiveness of their disposable drug-free anti-inflammatory devices. In a clinical study of Delayed Onset Muscle Soreness (DOMS) the company's devices were shown to be more effective in reducing muscle soreness than acetaminophen. In the study, the ActiPatch Therapy was tested against acetaminophen in reducing the pain of DOMS.
Try Best Penny Stocks, a web based financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
The report notes a highly significant difference between the control group and the group using the ActiPatch, with the control group indicating an average VAS pain level of 3,179 compared to 1,500 for the ActiPatch group where lower numbers indicate lower pain levels.
About BioElectronics Corporation
BioElectronics Corporation (BioElectronics) designs, develops and markets a variety of drug-free, anti-inflammatory patches for a range of medical indications. The Company's patch products, which are marketed under the name ActiPatch Therapy, deliver pulsed electromagnetic field therapy, an anti-inflammatory and pain relief therapy. The ActiPatch Therapy products combine a miniaturized microchip, power source and antenna in a soft, flexible outer envelope. When applied to the body, these devices deliver a pulsed radio frequency signal into the body on a 27 megahertz (MHz) frequency wave that induces a low frequency electromagnetic field to damaged cell tissue.
Sign up for the Try Best Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Try Best Penny Stocks is a financial web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
staff@trybestpennystocks.com
www.trybestpennystocks.com
Email Article to a friend
|
View Profile
Visit Blogs
|
NEWS ALERTS
Receive alerts for
Try Best Penny Stocks
to your inbox.
Sign up for TransWorldNews Alerts
TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
